Unknown

Dataset Information

Evaluating the impact of glucokinase activation on risk of cardiovascular disease: a Mendelian randomisation analysis.


ABSTRACT:

Background

Glucokinase activators (GKAs) are an emerging class of glucose lowering drugs that activate the glucose-sensing enzyme glucokinase (GK). Pending formal cardiovascular outcome trials, we applied two-sample Mendelian randomisation (MR) to investigate the impact of GK activation on risk of cardiovascular diseases.

Methods

We used independent genetic variants in or around the glucokinase gene meanwhile associated with HbA1c at genome-wide significance (P < 5 × 10-8) in the Meta-Analyses of Glucose and Insulin-related traits Consortium study (N = 146,806; European ancestry) as instrumental variables (IVs) to mimic the effects of GK activation. We assessed the association between genetically proxied GK activation and the risk of coronary artery dis

SUBMITTER: Wang K 

PROVIDER: S-EPMC9503210 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature